The development of quality indicators for systemic lupus erythematosus using electronic health data: A modified RAND appropriateness method

Nobuyuki Yajima, Yasushi Tsujimoto, Shingo Fukuma, Ken ei Sada, Sayaka Shimizu, Kakuya Niihata, Ryo Takahashi, Yoshihide Asano, Teruhisa Azuma, Hideto Kameda, Masataka Kuwana, Hitoshi Kohsaka, Mayumi Sugiura-Ogasawara, Katsuya Suzuki, Tsutomu Takeuchi, Yoshiya Tanaka, Naoto Tamura, Toshihiro Matsui, Tsuneyo Mimori, Shunichi FukuharaTatsuya Atsumi

Research output: Contribution to journalArticle

Abstract

Objective: Quality indicators (QIs) are tools that standardize evaluations in terms of the minimum acceptable quality of care, presumably contributing for the better management of patients with systemic lupus erythematosus (SLE). This study aimed to develop QIs for SLE using electronic health data. Methods: The modified RAND/UCLA Appropriateness Method was used to develop the QIs. First, a literature review was conducted. Second, the candidate QI items that were available to be evaluated using the electronic health data were extracted. Third, the appropriateness of the items was assessed via rating rounds and panelists’ discussions. Results: We found 3621 articles in the initial search. Finally, 34 studies were reviewed, from which 17 potential indicators were extracted as candidate QIs. Twelve indicators were selected as the final QI set through the process of appropriateness. The median appropriateness of these 12 indicators was at least 7.5, and all of them were without disagreement. The QI included assessment of disease activity, treatment of SLE, drug toxicity monitoring, treatment of glucocorticoid complications, and assessment of SLE complications. Conclusion: We formulated 12 QIs for the assessment of patients with SLE based on electronic medical data. Our QI set would be a practical tool as a quality measure.

Original languageEnglish
JournalModern Rheumatology
DOIs
Publication statusPublished - 2019 Jan 1

Fingerprint

Systemic Lupus Erythematosus
Health
Medical Electronics
Drug Monitoring
Quality of Health Care
Drug-Related Side Effects and Adverse Reactions
Glucocorticoids
Therapeutics

Keywords

  • Performance measures
  • quality indicators
  • quality measures
  • systemic lupus erythematosus

ASJC Scopus subject areas

  • Rheumatology

Cite this

The development of quality indicators for systemic lupus erythematosus using electronic health data : A modified RAND appropriateness method. / Yajima, Nobuyuki; Tsujimoto, Yasushi; Fukuma, Shingo; Sada, Ken ei; Shimizu, Sayaka; Niihata, Kakuya; Takahashi, Ryo; Asano, Yoshihide; Azuma, Teruhisa; Kameda, Hideto; Kuwana, Masataka; Kohsaka, Hitoshi; Sugiura-Ogasawara, Mayumi; Suzuki, Katsuya; Takeuchi, Tsutomu; Tanaka, Yoshiya; Tamura, Naoto; Matsui, Toshihiro; Mimori, Tsuneyo; Fukuhara, Shunichi; Atsumi, Tatsuya.

In: Modern Rheumatology, 01.01.2019.

Research output: Contribution to journalArticle

Yajima, N, Tsujimoto, Y, Fukuma, S, Sada, KE, Shimizu, S, Niihata, K, Takahashi, R, Asano, Y, Azuma, T, Kameda, H, Kuwana, M, Kohsaka, H, Sugiura-Ogasawara, M, Suzuki, K, Takeuchi, T, Tanaka, Y, Tamura, N, Matsui, T, Mimori, T, Fukuhara, S & Atsumi, T 2019, 'The development of quality indicators for systemic lupus erythematosus using electronic health data: A modified RAND appropriateness method', Modern Rheumatology. https://doi.org/10.1080/14397595.2019.1621419
Yajima, Nobuyuki ; Tsujimoto, Yasushi ; Fukuma, Shingo ; Sada, Ken ei ; Shimizu, Sayaka ; Niihata, Kakuya ; Takahashi, Ryo ; Asano, Yoshihide ; Azuma, Teruhisa ; Kameda, Hideto ; Kuwana, Masataka ; Kohsaka, Hitoshi ; Sugiura-Ogasawara, Mayumi ; Suzuki, Katsuya ; Takeuchi, Tsutomu ; Tanaka, Yoshiya ; Tamura, Naoto ; Matsui, Toshihiro ; Mimori, Tsuneyo ; Fukuhara, Shunichi ; Atsumi, Tatsuya. / The development of quality indicators for systemic lupus erythematosus using electronic health data : A modified RAND appropriateness method. In: Modern Rheumatology. 2019.
@article{611fe04583e946fa9f8079ef78555e5f,
title = "The development of quality indicators for systemic lupus erythematosus using electronic health data: A modified RAND appropriateness method",
abstract = "Objective: Quality indicators (QIs) are tools that standardize evaluations in terms of the minimum acceptable quality of care, presumably contributing for the better management of patients with systemic lupus erythematosus (SLE). This study aimed to develop QIs for SLE using electronic health data. Methods: The modified RAND/UCLA Appropriateness Method was used to develop the QIs. First, a literature review was conducted. Second, the candidate QI items that were available to be evaluated using the electronic health data were extracted. Third, the appropriateness of the items was assessed via rating rounds and panelists’ discussions. Results: We found 3621 articles in the initial search. Finally, 34 studies were reviewed, from which 17 potential indicators were extracted as candidate QIs. Twelve indicators were selected as the final QI set through the process of appropriateness. The median appropriateness of these 12 indicators was at least 7.5, and all of them were without disagreement. The QI included assessment of disease activity, treatment of SLE, drug toxicity monitoring, treatment of glucocorticoid complications, and assessment of SLE complications. Conclusion: We formulated 12 QIs for the assessment of patients with SLE based on electronic medical data. Our QI set would be a practical tool as a quality measure.",
keywords = "Performance measures, quality indicators, quality measures, systemic lupus erythematosus",
author = "Nobuyuki Yajima and Yasushi Tsujimoto and Shingo Fukuma and Sada, {Ken ei} and Sayaka Shimizu and Kakuya Niihata and Ryo Takahashi and Yoshihide Asano and Teruhisa Azuma and Hideto Kameda and Masataka Kuwana and Hitoshi Kohsaka and Mayumi Sugiura-Ogasawara and Katsuya Suzuki and Tsutomu Takeuchi and Yoshiya Tanaka and Naoto Tamura and Toshihiro Matsui and Tsuneyo Mimori and Shunichi Fukuhara and Tatsuya Atsumi",
year = "2019",
month = "1",
day = "1",
doi = "10.1080/14397595.2019.1621419",
language = "English",
journal = "Modern Rheumatology",
issn = "1439-7595",
publisher = "Springer Japan",

}

TY - JOUR

T1 - The development of quality indicators for systemic lupus erythematosus using electronic health data

T2 - A modified RAND appropriateness method

AU - Yajima, Nobuyuki

AU - Tsujimoto, Yasushi

AU - Fukuma, Shingo

AU - Sada, Ken ei

AU - Shimizu, Sayaka

AU - Niihata, Kakuya

AU - Takahashi, Ryo

AU - Asano, Yoshihide

AU - Azuma, Teruhisa

AU - Kameda, Hideto

AU - Kuwana, Masataka

AU - Kohsaka, Hitoshi

AU - Sugiura-Ogasawara, Mayumi

AU - Suzuki, Katsuya

AU - Takeuchi, Tsutomu

AU - Tanaka, Yoshiya

AU - Tamura, Naoto

AU - Matsui, Toshihiro

AU - Mimori, Tsuneyo

AU - Fukuhara, Shunichi

AU - Atsumi, Tatsuya

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objective: Quality indicators (QIs) are tools that standardize evaluations in terms of the minimum acceptable quality of care, presumably contributing for the better management of patients with systemic lupus erythematosus (SLE). This study aimed to develop QIs for SLE using electronic health data. Methods: The modified RAND/UCLA Appropriateness Method was used to develop the QIs. First, a literature review was conducted. Second, the candidate QI items that were available to be evaluated using the electronic health data were extracted. Third, the appropriateness of the items was assessed via rating rounds and panelists’ discussions. Results: We found 3621 articles in the initial search. Finally, 34 studies were reviewed, from which 17 potential indicators were extracted as candidate QIs. Twelve indicators were selected as the final QI set through the process of appropriateness. The median appropriateness of these 12 indicators was at least 7.5, and all of them were without disagreement. The QI included assessment of disease activity, treatment of SLE, drug toxicity monitoring, treatment of glucocorticoid complications, and assessment of SLE complications. Conclusion: We formulated 12 QIs for the assessment of patients with SLE based on electronic medical data. Our QI set would be a practical tool as a quality measure.

AB - Objective: Quality indicators (QIs) are tools that standardize evaluations in terms of the minimum acceptable quality of care, presumably contributing for the better management of patients with systemic lupus erythematosus (SLE). This study aimed to develop QIs for SLE using electronic health data. Methods: The modified RAND/UCLA Appropriateness Method was used to develop the QIs. First, a literature review was conducted. Second, the candidate QI items that were available to be evaluated using the electronic health data were extracted. Third, the appropriateness of the items was assessed via rating rounds and panelists’ discussions. Results: We found 3621 articles in the initial search. Finally, 34 studies were reviewed, from which 17 potential indicators were extracted as candidate QIs. Twelve indicators were selected as the final QI set through the process of appropriateness. The median appropriateness of these 12 indicators was at least 7.5, and all of them were without disagreement. The QI included assessment of disease activity, treatment of SLE, drug toxicity monitoring, treatment of glucocorticoid complications, and assessment of SLE complications. Conclusion: We formulated 12 QIs for the assessment of patients with SLE based on electronic medical data. Our QI set would be a practical tool as a quality measure.

KW - Performance measures

KW - quality indicators

KW - quality measures

KW - systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=85068132815&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068132815&partnerID=8YFLogxK

U2 - 10.1080/14397595.2019.1621419

DO - 10.1080/14397595.2019.1621419

M3 - Article

C2 - 31111758

AN - SCOPUS:85068132815

JO - Modern Rheumatology

JF - Modern Rheumatology

SN - 1439-7595

ER -